Moreover, immune dysregulation in IBD patients involves various interleukins, such as IL-6, IL-12, IL-17, and TNF-α, which not only exacerbate intestinal inflammation but affect mood and behaviour through their systemic effects. This evidence concerns the gene IL6 and irritable bowel syndrome.